Atlas Trials

MK-2206 for Recurrent Malignant Glioma

Clinical trial NCT01249105 · WITHDRAWN

Trial details

NCT number
NCT01249105
Sponsor
Dana-Farber Cancer Institute
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Glioma
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.